Skip to main content
Premium Trial:

Request an Annual Quote

Biacore Says Q1 2006 Sales Exceeded Expectations

NEW YORK, April 11 (GenomeWeb News) - Biacore said today that sales for the first quarter of 2006 were "better than current market expectations."

 

Biacore, based in Uppsala, Sweden, said that its Q1 sales increased by 19 percent over the same period in 2005. The company had previously anticipated a slowdown in revenues in the early part of 2006 following a record 23-percent increase in year-over-year sales in Q4 2005.

 

At the time, Biacore said it expected 2006 sales to increase "at approximately the same rate as in 2005 with modest growth in the first quarter."

 

Further details were not disclosed. Biacore will release its full earnings report on May 4.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.